An announcement was made by the aap Implantate AG that the members of the firm’s Supervisory Board have chosen Ms. Doctor med. Nathalie Krebs as their new Chairwoman. Prior to that, Doctor Krebs was appointed to the Supervisory Board of the firm by aap’s yearly General Meeting held on 21st of June 2019 in Berlin with a strong majority of 99.99 percent. Her appointment is effective from the end of the Yearly General Meeting on 21st of June 2019 until the end of the Yearly General Meeting which resolves on the discharge of the Supervisory Board for the financial year 2021.
Former Chairman, as well as, member of the Supervisory Board at aap, Biense Visser stated that in Doctor Krebs we are pleased to have gained a proven specialist in medicine & business, as well as, a strong personality for the Supervisory Board of aap. He said that she has extensive experience in the fields of medical technology, pharma, and consulting firms and is also active in other Supervisory Bodies of various business enterprises with a medical alignment. We are looking forward to the co-operation & are definitely convinced that she will bring benefits to aap through her comprehensive expertise.
Ms. Doctor. Med. Krebs got her degree from the University Basel, Switzerland. At present, she is a member of the Board of Directors of the various firm and has broad experience based on the multiple responsible positions in the pharma industry, in med tech & with consulting firms inclusive of the Boston Consulting Group & Bayer.
aap Implantate AG is a medical device firm which develops, manufactures, and markets trauma products for orthopedics in Germany and the United States. The company offers LOQTEQ, which is a functional plating system for the fracture treatment; and a vast range of standard plates, and cannulated screws.